Pinatuzumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5093
Add to Compare
$306.00

Pinatuzumab Biosimilar - Research Grade

Product Information:

ichorbio’s Pinatuzumab Biosimilar is for Research Use Only (RUO)

Target:

CD22

Size:

This biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG1(E356D/M358L)-Kappa

Host:

CHO Cells

Species Reactivity:

Human

Specificity:

Detects human CD22.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Formulation:

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity:

>95% by SDS-PAGE

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Application Notes:

This biosimilar is for research use only (RUO).

More Information
Concentration 6mg/ml
Isotype Human IgG1(E356D/M358L)-Kappa
Host CHO Cells
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Endotoxin <1EU/mg Determined by LAL gel clotting assay
Purity ≥95% monomer by analytical SEC, >95% by SDS Page
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human CD22
Species Reactivity Human
Target CD22
Shipping Conditions Blue ice
background Uses the same sequence as the therapeutic antibody Pinatuzumab
Other names CAT-8015,GCR-8015,HA22,(sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Pinatuzumab Biosimilar - Research Grade
Your Rating
Back to Top